???pagination.result.count???
???pagination.result.page???
1
Role of SLC5A8, a plasma membrane transporter and a tumor suppressor, in the antitumor activity of dichloroacetate. , Babu E., Oncogene. September 22, 2011; 30 (38): 4026-37.
Diclofenac-induced stimulation of SMCT1 (SLC5A8) in a heterologous expression system: a RPE specific phenomenon. , Ananth S., Biochem Biophys Res Commun. March 26, 2010; 394 (1): 75-80.
Anionic leak currents through the Na+/monocarboxylate cotransporter SMCT1. , Coady MJ., Am J Physiol Cell Physiol. January 1, 2010; 298 (1): C124-31.
Transport of nicotinate and structurally related compounds by human SMCT1 (SLC5A8) and its relevance to drug transport in the mammalian intestinal tract. , Gopal E., Pharm Res. March 1, 2007; 24 (3): 575-84.
Na(+)/monocarboxylate transport (SMCT) protein expression correlates with survival in colon cancer: molecular characterization of SMCT. , Paroder V., Proc Natl Acad Sci U S A. May 9, 2006; 103 (19): 7270-5.
The human tumour suppressor gene SLC5A8 expresses a Na+-monocarboxylate cotransporter. , Coady MJ., J Physiol. June 15, 2004; 557 (Pt 3): 719-31.
Functional identification of SLC5A8, a tumor suppressor down-regulated in colon cancer, as a Na(+)-coupled transporter for short-chain fatty acids. , Miyauchi S., J Biol Chem. April 2, 2004; 279 (14): 13293-6.